Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Mossad unveils network of Hamas terror infrastructure across Europe - 2Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- 3Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
- 4The Difficulties of Getting a Green Card in the US
- 5Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point
- Manual for Instructive Application for Youngsters
- Audits of 6 European Busssiness Class Flights
- Shah Capital pushes for Novavax sale, warns of proxy fight
- Cuba fights to contain spread of mosquito-borne chikungunya virus
- Washington resident contracts bird flu, first human case in U.S. since February
- Pick Your #1 Kind Of Treat
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
